EUROFINS SCIENTIFIC (ERF.PA) Fundamental Analysis & Valuation

EPA:ERF • FR0014000MR3

63.18 EUR
-0.48 (-0.75%)
Last: Mar 11, 2026, 05:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This ERF.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

ERF gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 22 industry peers in the Life Sciences Tools & Services industry. ERF has only an average score on both its financial health and profitability. ERF is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. ERF.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ERF was profitable.
  • In the past year ERF had a positive cash flow from operations.
  • In the past 5 years ERF has always been profitable.
  • Each year in the past 5 years ERF had a positive operating cash flow.
ERF.PA Yearly Net Income VS EBIT VS OCF VS FCFERF.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • ERF has a Return On Assets (3.73%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 9.02%, ERF perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • ERF has a Return On Invested Capital of 9.81%. This is in the better half of the industry: ERF outperforms 68.18% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ERF is significantly below the industry average of 14.22%.
  • The last Return On Invested Capital (9.81%) for ERF is above the 3 year average (8.67%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROIC 9.81%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ERF.PA Yearly ROA, ROE, ROICERF.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a Profit Margin value of 6.06%, ERF perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ERF has declined.
  • The Operating Margin of ERF (16.10%) is comparable to the rest of the industry.
  • ERF's Operating Margin has declined in the last couple of years.
  • ERF has a worse Gross Margin (24.29%) than 81.82% of its industry peers.
  • ERF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
ERF.PA Yearly Profit, Operating, Gross MarginsERF.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ERF.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ERF is still creating some value.
  • Compared to 1 year ago, ERF has less shares outstanding
  • ERF has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ERF has a worse debt to assets ratio.
ERF.PA Yearly Shares OutstandingERF.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ERF.PA Yearly Total Debt VS Total AssetsERF.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • ERF has an Altman-Z score of 2.57. This is not the best score and indicates that ERF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ERF has a Altman-Z score (2.57) which is in line with its industry peers.
  • The Debt to FCF ratio of ERF is 5.14, which is a neutral value as it means it would take ERF, 5.14 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.14, ERF is doing good in the industry, outperforming 68.18% of the companies in the same industry.
  • ERF has a Debt/Equity ratio of 0.82. This is a neutral value indicating ERF is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.82, ERF perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Altman-Z 2.57
ROIC/WACC1.14
WACC8.62%
ERF.PA Yearly LT Debt VS Equity VS FCFERF.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • ERF has a Current Ratio of 1.09. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • ERF has a Current ratio (1.09) which is comparable to the rest of the industry.
  • ERF has a Quick Ratio of 1.03. This is a normal value and indicates that ERF is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, ERF is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.03
ERF.PA Yearly Current Assets VS Current LiabilitesERF.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ERF.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 12.73% over the past year.
  • Measured over the past years, ERF shows a decrease in Earnings Per Share. The EPS has been decreasing by -3.15% on average per year.
  • ERF shows a decrease in Revenue. In the last year, the revenue decreased by -2.80%.
  • The Revenue has been growing slightly by 4.43% on average over the past years.
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%

3.2 Future

  • Based on estimates for the next years, ERF will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.11% on average per year.
  • ERF is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.47% yearly.
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERF.PA Yearly Revenue VS EstimatesERF.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ERF.PA Yearly EPS VS EstimatesERF.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

6

4. ERF.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 16.98 indicates a correct valuation of ERF.
  • ERF's Price/Earnings ratio is rather cheap when compared to the industry. ERF is cheaper than 81.82% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ERF to the average of the S&P500 Index (26.25), we can say ERF is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 16.19, ERF is valued correctly.
  • Based on the Price/Forward Earnings ratio, ERF is valued cheaper than 86.36% of the companies in the same industry.
  • ERF's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.39.
Industry RankSector Rank
PE 16.98
Fwd PE 16.19
ERF.PA Price Earnings VS Forward Price EarningsERF.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ERF is valued cheaply inside the industry as 86.36% of the companies are valued more expensively.
  • ERF's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ERF is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.35
EV/EBITDA 8.41
ERF.PA Per share dataERF.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ERF does not grow enough to justify the current Price/Earnings ratio.
  • ERF's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.04
PEG (5Y)N/A
EPS Next 2Y11.81%
EPS Next 3Y13.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. ERF.PA Dividend Analysis

5.1 Amount

  • ERF has a Yearly Dividend Yield of 1.10%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.45, ERF pays a better dividend. On top of this ERF pays more dividend than 86.36% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.82, ERF is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

  • The dividend of ERF is nicely growing with an annual growth rate of 16.09%!
Dividend Growth(5Y)16.09%
Div Incr Years1
Div Non Decr Years1
ERF.PA Yearly Dividends per shareERF.PA Yearly Dividends per shareYearly Dividends per share 2018 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 26.80% of the earnings are spent on dividend by ERF. This is a low number and sustainable payout ratio.
  • The dividend of ERF is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP26.8%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
ERF.PA Yearly Income VS Free CF VS DividendERF.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ERF.PA Dividend Payout.ERF.PA Dividend Payout, showing the Payout Ratio.ERF.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ERF.PA Fundamentals: All Metrics, Ratios and Statistics

EUROFINS SCIENTIFIC

EPA:ERF (3/11/2026, 5:36:15 PM)

63.18

-0.48 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)04-22
Inst Owners33.9%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.51B
Revenue(TTM)6.76B
Net Income(TTM)409.70M
Analysts72
Price Target72.41 (14.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.6
Dividend Growth(5Y)16.09%
DP26.8%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.43%
PT rev (3m)10.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.42%
EPS NY rev (3m)-1.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.98%
Revenue NY rev (3m)-0.9%
Valuation
Industry RankSector Rank
PE 16.98
Fwd PE 16.19
P/S 1.7
P/FCF 13.35
P/OCF 8.23
P/B 2.53
P/tB N/A
EV/EBITDA 8.41
EPS(TTM)3.72
EY5.89%
EPS(NY)3.9
Fwd EY6.18%
FCF(TTM)4.73
FCFY7.49%
OCF(TTM)7.68
OCFY12.16%
SpS37.09
BVpS24.94
TBVpS-4.41
PEG (NY)2.04
PEG (5Y)N/A
Graham Number45.69
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 9.02%
ROCE 12.72%
ROIC 9.81%
ROICexc 10.81%
ROICexgc 34.71%
OM 16.1%
PM (TTM) 6.06%
GM 24.29%
FCFM 12.76%
ROA(3y)3.11%
ROA(5y)4.62%
ROE(3y)6.89%
ROE(5y)9.79%
ROIC(3y)8.67%
ROIC(5y)10.11%
ROICexc(3y)9.6%
ROICexc(5y)11.01%
ROICexgc(3y)30.56%
ROICexgc(5y)36.02%
ROCE(3y)11.39%
ROCE(5y)13.27%
ROICexgc growth 3Y-1.05%
ROICexgc growth 5Y-8.2%
ROICexc growth 3Y1.16%
ROICexc growth 5Y-4.51%
OM growth 3Y1.4%
OM growth 5Y-3.07%
PM growth 3Y-11.18%
PM growth 5Y-8.18%
GM growth 3Y2.52%
GM growth 5Y-1.34%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 5.14
Debt/EBITDA 2.05
Cap/Depr 74.23%
Cap/Sales 7.94%
Interest Coverage 9.42
Cash Conversion 77.25%
Profit Quality 210.5%
Current Ratio 1.09
Quick Ratio 1.03
Altman-Z 2.57
F-Score6
WACC8.62%
ROIC/WACC1.14
Cap/Depr(3y)77.81%
Cap/Depr(5y)87.04%
Cap/Sales(3y)8%
Cap/Sales(5y)8.27%
Profit Quality(3y)205.64%
Profit Quality(5y)166.63%
High Growth Momentum
Growth
EPS 1Y (TTM)12.73%
EPS 3Y-9.04%
EPS 5Y-3.15%
EPS Q2Q%6.78%
EPS Next Y8.32%
EPS Next 2Y11.81%
EPS Next 3Y13.96%
EPS Next 5Y16.11%
Revenue 1Y (TTM)-2.8%
Revenue growth 3Y0.22%
Revenue growth 5Y4.43%
Sales Q2Q%4.3%
Revenue Next Year4.69%
Revenue Next 2Y5.62%
Revenue Next 3Y5.95%
Revenue Next 5Y7.47%
EBIT growth 1Y4.52%
EBIT growth 3Y1.62%
EBIT growth 5Y1.23%
EBIT Next Year81.37%
EBIT Next 3Y28.68%
EBIT Next 5Y24.78%
FCF growth 1Y9.1%
FCF growth 3Y21.91%
FCF growth 5Y-0.13%
OCF growth 1Y6.07%
OCF growth 3Y7.18%
OCF growth 5Y2.72%

EUROFINS SCIENTIFIC / ERF.PA FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ERF.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ERF.PA.


What is the valuation status for ERF stock?

ChartMill assigns a valuation rating of 5 / 10 to EUROFINS SCIENTIFIC (ERF.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EUROFINS SCIENTIFIC?

EUROFINS SCIENTIFIC (ERF.PA) has a profitability rating of 4 / 10.


What is the earnings growth outlook for EUROFINS SCIENTIFIC?

The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ERF.PA) is expected to grow by 8.32% in the next year.


Can you provide the dividend sustainability for ERF stock?

The dividend rating of EUROFINS SCIENTIFIC (ERF.PA) is 6 / 10 and the dividend payout ratio is 26.8%.